Loading...
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
BACKGROUND: Pentraxin 3 is proposed to be a marker of inflammation and cardiovascular risk, but its role in inflammatory rheumatic diseases (IRDs) is still uncertain. Therefore, we wanted to examine if anti-rheumatic treatment reduced serum PTX3 (s-PTX3) levels in IRDs, and if s-PTX3 levels were rel...
Na minha lista:
Udgivet i: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Public Library of Science
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5321277/ https://ncbi.nlm.nih.gov/pubmed/28225768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0169830 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|